# REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription

> **NCT07424118** · NA · NOT_YET_RECRUITING · sponsor: **Evelyn Vanina Re** · enrollment: 240 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **BEHAVIORAL:** Intensive Lifestyle Intervention
- **OTHER:** Pharmacological Deprescribing Algorithm
- **OTHER:** Standard Medical Care

## Key facts

- **NCT ID:** NCT07424118
- **Lead sponsor:** Evelyn Vanina Re
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2026-11
- **Final completion:** 2026-12
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07424118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07424118, "REMIDEP-HTA Program for Hypertension Remission and Medication Deprescription". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07424118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*